Versant Ventures VI GP-GP, LLC

Related Filers (28)

Ownership (40)

4
Wednesday, 1/4/2023
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/11/2022
Century Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/7/2022
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/3/2022
Tempest Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/2/2022
Century Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/7/2022
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/28/2021
Century Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/23/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/20/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/9/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 7/6/2021
Tempest Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 7/1/2021
Graphite Bio, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/30/2021
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/24/2021
Graphite Bio, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/23/2021
Century Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/23/2021
Monte Rosa Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 6/17/2021
Century Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/3/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/14/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/7/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/30/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/19/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/18/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/2/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/19/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/17/2020
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/21/2020
Pandion Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/16/2020
Pandion Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4/A
Friday, 7/10/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 7/10/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/25/2020
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/18/2020
Repare Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 3/3/2020
Passage BIO, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/27/2020
Passage BIO, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 1/21/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/15/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/9/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/6/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/4/2019
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/30/2019
Oyster Point Pharma, Inc.: Initial statement of beneficial ownership of securities
Show More